NCT01110876 2021-08-25Phase I / II Vorinostat, Erlotinib and Temozolomide for Recurrent Glioblastoma Multiforme (GBM)M.D. Anderson Cancer CenterPhase 1/2 Terminated21 enrolled 8 charts